ENDPQ — Endo International Share News
0.000.00%
Last trade - 00:00- $0.14m
- $7.37bn
- $2.01bn
Brief: Endo Provides Top-Line Results From Phase 2 Study Of Collagenase Clostridium Histolyticum In Participants With Adhesive Capsulitis Of The Shoulder
Drugmaker Endo misses $38 million interest payment amid bankruptcy talks
Form SAR 6 - Endo International Plc
Brief: Endo International Executes Agreement With TLC To Commercialize Phase 3 Orthopedic Product For Treatment Of Osteoarthritis Knee Pain
Brief: TLC BioSciences Announces TLC599 Agreement With Endo International
Brief: S&P Dow Jones Indices Says Under Armour And IPG Photonics Will Replace Trinity Industries Inc. And Yelp Inc. Respectively In The S&P Midcap 400
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:39 PM
Endo International slumps on report of debt-restructuring talks
Brief: Endo International Begins Negotiations With Creditors About Possible Restructuring Of More Than $8 Bln In Debt - WSJ
BMO cuts Endo's PT on weak Q2 forecast, scarce H2 visibility
U.S. STOCKS ON THE MOVE-GoPro Inc, Humanigen Inc, Redfin Corp
U.S. STOCKS ON THE MOVE-Under Armour, Cigna, Illumina, Nike, FuboTV
Endo International slumps on dour Q2 forecast
Brief: Endo Reports First-Quarter 2022 Financial Results
Brief: Endo Aesthetics To Introduce New Clinical Study Of Qwo® (Collagenase Clostridium Histolyticum-Aaes) At The Annual Scale Meeting
Brief: Endo Aesthetics To Introduce New Clinical Study Of Qwo® (Collagenase Clostridium Histolyticum-Aaes) At The Annual Scale Meeting
Brief: Endo International PLC QTRLY Loss Per Share From Continuing Operations $0.28
Walgreens reaches $683 mln opioid settlement with Florida (updated)
Walgreens reaches $683 mln opioid settlement with Florida